Minimisation of Blood Pressure Variability and Postoperative Nausea and Vomiting
SICK
The Effect of Minimizing Blood Pressure Variability on Postoperative Nausea and Vomiting in Women Undergoing Non-cardiac Surgery With Minor to Moderate Risk - a Prospective Randomized Clinical Trial
1 other identifier
interventional
272
1 country
1
Brief Summary
Intraoperative hypotension is associated with postoperative nausea and vomiting (PONV). Even though the exact mechanism linking PONV and hypotension is still unclear, a reduced intestinal tissue perfusion might trigger nausea and vomiting. Still to date only limited data evaluating intraoperative blood pressure and the incidence of PONV after general anesthesia exits. Furthermore, the effect of intraoperative blood pressure variability on the incidence of PONV has not been investigated yet. Therefore, we will test our primary hypothesis that the incidence of PONV during the early (0-2h) postoperative period will be minimized by targeting intraoperative blood pressure variability to a SPB of 120±5mmHg by using a continuous vasopressor infusion in female patients undergoing elective minor to moderate risk non-cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 24, 2022
CompletedFirst Posted
Study publicly available on registry
October 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 11, 2023
July 1, 2023
3 years
October 24, 2022
July 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PONV
Incidence of postoperative nausea and vomiting within the first two postoperative hours.
First two postoperative hours
Secondary Outcomes (3)
Secondary Outcome 1: Late PONV
First three postoperative days
Secondary Outcome 2: Modified Aldrete Score
First two postoperative hours
Secondary Outcome 3: Ready for Hospital Discharge Scale
First three postoperative days
Other Outcomes (4)
Exploratory Outcome 1: Intraoperative cerebral oxygen saturation between study groups
Throughout surgery
Exploratory Outcome 2: Intraoperative cerebral oxygen saturation between patients, who experienced PONV, and patients without PONV
Throughout surgery and first two postoperative hours
Exploratory Outcome 3: Impact of Event Scale-Revised
Before surgery
- +1 more other outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALIntraoperative blood pressure management will be performed to maintain a systolic blood pressure of 120 ±5mmHg using a continuous infusion of a vasopressor starting at induction of anesthesia.
Standard of Care Group
NO INTERVENTIONIntraoperative blood pressure management will be performed according to local clinical standard of care.
Interventions
Intraoperative blood pressure management will be performed to maintain a systolic blood pressure of 120 ±5mmHg using a continuous infusion of a vasopressor starting at induction of anaesthesia.
Eligibility Criteria
You may qualify if:
- Women 18-50 years of age at time of surgery
- ASA physical status I and II
- Scheduled for elective minor or moderate risk non-cardiac surgery with expected time of surgery ≥1 hour
You may not qualify if:
- Patients undergoing emergency surgery
- Scheduled for pheochromocytoma surgery
- Nausea and/or vomiting on the morning before surgery
- Taking anti-emetic drugs
- Pregnancy
- Dysfunction of the vestibular system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Reiterer, MD
Medical University of Vienna
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 24, 2022
First Posted
October 27, 2022
Study Start
October 1, 2022
Primary Completion
October 1, 2025
Study Completion
February 1, 2026
Last Updated
July 11, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share
We will not share any individual participant data